News Nuo Therapeutics, Inc.

Equities

AURX

US67059V2097

Market Closed - OTC Markets Other stock markets 03:13:42 2024-05-01 pm EDT			5-day change	1st Jan Change
0.8 ^USD	0.00%		0.00%	+45.45%

Apr. 19	Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 19	Exor-backed NUO invests in Italian teenage clothing chain Subdued	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Exor-backed NUO invests in Italian teenage clothing chain Subdued	Mar. 19	RE
Nuo Therapeutics, Inc. announced that it has received $0.9625 million in funding	Dec. 18	CI
Nuo Therapeutics, Inc. announced that it expects to receive $0.9625 million in funding	Dec. 07	CI
Nuo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Nuo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Insider Buy: Nuo Therapeutics	23-08-04	MT
Nuo Therapeutics, Inc. announced that it has received $1.035 million in funding	23-07-31	CI
Nuo Therapeutics, Inc. announced that it expects to receive $1.035 million in funding	23-07-25	CI
Nuo Therapeutics Selects to Exhibit AurixÂ® System At Vizient Innovative Technology Exchange	23-06-26	CI
Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange	23-06-26	AQ
Nuo Therapeutics’ Aurix® System Added To Wound Care Formulary Of Wound Care Advantage	23-06-22	AQ
Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-04-17	AQ
Nuo Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	23-04-16	CI
NUO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-05	AQ
Nuo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04	CI
NUO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-04	AQ
NUO THERAPEUTICS, INC. : Shareholder Director Nominations, Other Events (form 8-K)	22-09-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nuo Therapeutics, Inc.

Equities

AURX

US67059V2097

Summary

Filters